Loading company…
Mperia Therapeutics, a Montreal spin-off of Amorchem Ventures, develops immunotherapy for chronic inflammation and macular degeneration.
Founded in 2016 and based in Montreal, Quebec, Mperia Therapeutics Inc. was spun off from Amorchem Ventures. The firm operates an immunotherapy technology aimed at chronic inflammation and age-related macular degeneration. It is at Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in